Hemodynamic response to sildenafil, nitric oxide, and iloprost in primary pulmonary hypertension.

Leuchte, Hanno H; Schwaiblmair, Martin; Baumgartner, Rainer A; Neurohr, Claus F; Kolbe, Tilman; Behr, Jürgen

Leuchte, Hanno H; Schwaiblmair, Martin; Baumgartner, Rainer A; Neurohr, Claus F; Kolbe, Tilman; Behr, Jürgen.

Affiliation

Leuchte HH; Department of Internal Medicine I, Section for Pulmonary Diseases, Klinikum Grosshadern, Ludwig-Maximilians-University Munich, Munich, Germany. hleuchte@helios.med.uni-muenchen.de

Chest ; 125(2): 580-6, 2004 Feb.

Article in En | MEDLINE | ID: mdl-14769741

Subject(s)

Hemodynamics/drug effects; Hypertension, Pulmonary/drug therapy; Iloprost/administration & dosage; Nitric Oxide/administration & dosage; Piperazines/administration & dosage; Vasodilator Agents/administration & dosage; Administration, Inhalation; Administration, Oral; Adult; Cardiac Catheterization; Dose-Response Relationship, Drug; Drug Administration Schedule; Female; Follow-Up Studies; Humans; Hypertension, Pulmonary/diagnosis; Male; Middle Aged; Prospective Studies; Purines; Risk Assessment; Sampling Studies; Severity of Illness Index; Sildenafil Citrate; Sulfones; Treatment Outcome; Vascular Resistance/drug effects

Search on Google

XML

PubMed Links

Collection: 01-internacional Database: MEDLINE Main subject: Piperazines / Vasodilator Agents / Iloprost / Hemodynamics / Hypertension, Pulmonary / Nitric Oxide Type of study: Diagnostic_studies / Etiology_studies / Observational_studies / Prognostic_studies Limits: Adult / Female / Humans / Male / Middle aged Language: En Journal: Chest Year: 2004 Type: Article Affiliation country: Germany

Search on Google

XML

PubMed Links